Subtype
Hepatopancreatobiliary Carcinoma
CI-CAN-00002859Explore in graph →
1,360 active trials21 approved drugs69 evidence items
- NCIt
- C214986
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002859Explore in graph →
Clinical trials
5,150 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (645)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00091182 | Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment | completed | Phase 2 | 180 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT00238394 | Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer | completed | Phase 2 | 44 | National Cancer Institute (NCI)NIH | 1 | Jun 5, 2013 | clinicaltrials |
| NCT01861912 | Arsenic Trioxide TACE and Intravenous Administration in Unresectable Hepatocellular Carcinoma(ACTION) | unknown | Phase 2 / Phase 3 | 258 | Guangdong Provincial People's HospitalOTHER | 0 | Jun 5, 2013 | clinicaltrials |
| NCT00033462 | Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer | completed | Phase 2 | 78 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00075439 | Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors | completed | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00077441 | Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 2 | 55 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00084461 | Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors | terminated | Phase 2 | 25 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00397787 | Sunitinib in Treating Patients With Metastatic Pancreatic Cancer That Progressed After First-Line Therapy With Gemcitabine | completed | Phase 2 | 64 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT01858207 | Combine TACE and RFA Versus RFA Monotherapy in Unilobar HCC of 3.1 to 7 cm Patient | unknown | Phase 2 | 60 | Shi-Ming LinOTHER | 1 | May 23, 2013 | clinicaltrials |
| NCT00363051 | Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy | completed | Phase 2 | 160 | Novartis PharmaceuticalsINDUSTRY | 11 | May 10, 2013 | clinicaltrials |
| NCT00242502 | Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery | completed | Phase 2 | 62 | M.D. Anderson Cancer CenterOTHER | 1 | May 6, 2013 | clinicaltrials |
| NCT01821482 | A Study of DC-CIK to Treat Hepatocellular Carcinoma | unknown | Phase 2 | 100 | Guangxi Medical UniversityOTHER | 1 | Apr 12, 2013 | clinicaltrials |
| NCT00405873 | Study to Evaluate Tumour Response in Cancer Patients With Advanced Hepatocellular Carcinoma (Liver Cancer) With AMT2003 | terminated | Phase 2 | 73 | Auron Healthcare GmbHINDUSTRY | 1 | Mar 20, 2013 | clinicaltrials |
| NCT00988741 | Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic Therapy | completed | Phase 2 | 107 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 5 | Feb 28, 2013 | clinicaltrials |
| NCT00071994 | Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer) | completed | Phase 2 | 59 | National Cancer Institute (NCI)NIH | 1 | Feb 27, 2013 | clinicaltrials |
| NCT01739465 | Comparison of Endoscopic Radiofrequency Ablation Versus Photodynamic Therapy for Inoperable Cholangiocarcinoma | unknown | Phase 2 / Phase 3 | 120 | Guangzhou Medical UniversityOTHER | 1 | Feb 26, 2013 | clinicaltrials |
| NCT00959946 | Study Of Bosutinib With Capecitabine In Solid Tumors And Locally Advanced Or Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 32 | PfizerINDUSTRY | 6 | Feb 22, 2013 | clinicaltrials |
| NCT01394497 | Use of N-Acetylcysteine During Liver Procurement | completed | Phase 2 | 140 | Azienda Ospedaliera di PadovaOTHER | 1 | Feb 18, 2013 | clinicaltrials |
| NCT00028834 | Bevacizumab and Gemcitabine in Treating Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 24, 2013 | clinicaltrials |
| NCT00047333 | Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed | terminated | Phase 2 | 80 | National Cancer Institute (NCI)NIH | 1 | Jan 23, 2013 | clinicaltrials |
| NCT00075647 | CCI-779 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 40 | National Cancer Institute (NCI)NIH | 1 | Jan 17, 2013 | clinicaltrials |
| NCT00238212 | S0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma | completed | Phase 2 | 50 | National Cancer Institute (NCI)NIH | 1 | Jan 14, 2013 | clinicaltrials |
| NCT00517920 | Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 44 | AbbVie (prior sponsor, Abbott)INDUSTRY | 4 | Jan 4, 2013 | clinicaltrials |
| NCT01567930 | Temsirolimus as Second-line Therapy in HCC | unknown | Phase 2 | 25 | University of Tennessee Cancer InstituteOTHER | 1 | Dec 17, 2012 | clinicaltrials |
| NCT01392131 | Safety and Efficacy of Oncoxin in Hepatocellular Carcinoma (HCC) | unknown | Phase 1 / Phase 2 | 40 | Clinical Research Organization, Dhaka, BangladeshOTHER | 1 | Dec 12, 2012 | clinicaltrials |
| NCT00966251 | Safety and Tolerability Study of the Monoclonal Antibody CT-011 in Patients With Hepatocellular Carcinoma | terminated | Phase 1 / Phase 2 | 2 | CureTech LtdINDUSTRY | 1 | Oct 23, 2012 | clinicaltrials |
| NCT00843934 | Trial of Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma(ACE500) | unknown | Phase 2 / Phase 3 | 450 | Nihon UniversityOTHER | 1 | Oct 19, 2012 | clinicaltrials |
| NCT01655641 | Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery(TMGS) | unknown | Phase 2 / Phase 3 | 118 | Tribhuvan University Teaching Hospital, Institute Of Medicine.OTHER | 1 | Oct 16, 2012 | clinicaltrials |
| NCT00614913 | Proton Beam Therapy for Treatment of Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 76 | Loma Linda UniversityOTHER | 1 | Aug 20, 2012 | clinicaltrials |
| NCT00080236 | Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation | completed | Phase 2 | 99 | Conatus Pharmaceuticals Inc.INDUSTRY | 2 | Aug 10, 2012 | clinicaltrials |
| NCT00713687 | Gemcitabine/Oxaliplatin and Photodynamic Therapy in Cholangiocarcinoma(GemOx-PDT) | withdrawn | Phase 2 | 0 | Technical University of MunichOTHER | 1 | Aug 10, 2012 | clinicaltrials |
| NCT00522405 | Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma | unknown | Phase 2 / Phase 3 | — | All India Institute of Medical SciencesOTHER | 1 | Jul 16, 2012 | clinicaltrials |
| NCT01438450 | Oral Chemotherapy Versus Supportive Therapy In The Treatment Of Unresectable Hepatocellular Carcinoma(OTCHCC) | unknown | Phase 2 / Phase 3 | 74 | All India Institute of Medical SciencesOTHER | 1 | Jul 13, 2012 | clinicaltrials |
| NCT00731445 | Phase I/II Study of Z-208 in Advanced Hepatocellular Carcinoma (HCC) | completed | Phase 1 / Phase 2 | 43 | Zeria PharmaceuticalINDUSTRY | 1 | Jul 3, 2012 | clinicaltrials |
| NCT01008358 | Anti-CTLA-4 Human Monoclonal Antibody CP-675,206 in Patients With Advanced Hepatocellular Carcinoma | completed | Phase 2 | 20 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | Jun 8, 2012 | clinicaltrials |
| NCT00618384 | TACE and Sorafenib for Advanced Hepatocellular Carcinoma (HCC)(SOCRATES) | terminated | Phase 2 | 43 | Heinrich-Heine University, DuesseldorfOTHER | 1 | Jun 7, 2012 | clinicaltrials |
| NCT00919009 | Combination of Transcatheter Arterial Chemoembolization (TACE) and Sorafenib for Patients With Unresectable Hepatocellular Carcinoma (HCC) | completed | Phase 2 | 50 | National Cancer Center, KoreaOTHER_GOV | 1 | May 30, 2012 | clinicaltrials |
| NCT01605734 | TACE Combinated With Sorafenib in Treating Patients With Unresectable Hepatocellular Carcinoma | unknown | Phase 2 | 120 | Shandong Cancer Hospital and InstituteOTHER | 1 | May 25, 2012 | clinicaltrials |
| NCT00867750 | SIR-Spheres® Microspheres Versus Transarterial Chemoembolisation in Patients With Unresectable Hepatocellular Carcinoma(SIRTACE) | completed | Phase 2 | 28 | Sirtex MedicalINDUSTRY | 2 | May 7, 2012 | clinicaltrials |
| NCT00775073 | Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001 | completed | Phase 2 | 33 | Gerhard TreiberINDIV | 1 | Apr 30, 2012 | clinicaltrials |
| NCT01556815 | Sorafenib Combined With Transarterial Chemoembolization in Treating HBV-infected Patients With Intermediate Hepatocellular Carcinoma | unknown | Phase 2 | 40 | Shandong Cancer Hospital and InstituteOTHER | 1 | Apr 25, 2012 | clinicaltrials |
| NCT01194206 | Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant | withdrawn | Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Apr 18, 2012 | clinicaltrials |
| NCT01320241 | Radiation Stent Versus Self-expanding Metallic Stents (SEMS) for Palliative Treatment of Malignant Biliary Stricture | completed | Phase 2 | 24 | Southeast University, ChinaOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT00784290 | Phase I/II Study of TSU-68 for Advanced Hepatocellular Carcinoma | completed | Phase 1 / Phase 2 | 35 | Taiho Pharmaceutical Co., Ltd.INDUSTRY | 1 | Mar 26, 2012 | clinicaltrials |
| NCT01092091 | Study of Pegylated Human Recombinant Arginase for Liver Cancer (BCT-100-002)(BCT-100-002) | completed | Phase 1 / Phase 2 | 20 | Bio-Cancer Treatment International LimitedINDUSTRY | 1 | Mar 14, 2012 | clinicaltrials |
| NCT01543412 | Second Line Chemotherapy for Advanced Pancreatic Cancer(SLAP) | completed | Phase 2 | 50 | Gruppo Italiano per lo studio dei Carcinomi dell'Apparato DigerenteOTHER | 1 | Mar 5, 2012 | clinicaltrials |
| NCT00151671 | Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer(IMPACT) | terminated | Phase 2 / Phase 3 | 35 | Rennes University HospitalOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT01533324 | S-1/LV One Week on and One Week Off Regimen in Advanced Hepatocellular Carcinoma (HCC) | unknown | Phase 2 | 32 | Second Military Medical UniversityOTHER | 1 | Feb 15, 2012 | clinicaltrials |
| NCT00913198 | A Study of CP-4126 in Patients With Advanced Pancreatic Cancer | completed | Phase 2 | 21 | Clavis PharmaINDUSTRY | 2 | Feb 10, 2012 | clinicaltrials |
| NCT01525719 | Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma(CRAD001T) | unknown | Phase 2 | 40 | Ratchavithi HospitalOTHER_GOV | 0 | Feb 3, 2012 | clinicaltrials |
Data updated 23 days agoSource updated Jun 5, 2013source: clinicaltrials